Clinical Trial

Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal Block in Patients Undergoing Breast Cancer Surgery

Study acronym: SPSIP-RIB
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This randomized clinical trial aims to evaluate and compare the analgesic efficacy of the Serratus Posterior Superior Intercostal Plane (SPSIP) and Rhomboid Intercostal Block in patients undergoing Breast Cancer Surgery With Axillary Lymph Node Dissection. The primary outcome is Visual Analog Scale (VAS) during the first 24 hours after surgery. Secondary outcomes include total opioid consumption, requirement for rescue analgesia, block performance time, block-related and systemic side effects (hematoma, pneumothorax, local anesthetic toxicity, vascular puncture, infection), Patient satisfaction assessed using a Likert scale, quality of recovery assessed using the QoR-15 questionnaire.
Protocol Amendment History 3 changes
notable Enrollment increased: 50 -> 60 participants 2026-05-06
notable Primary completion pushed: 2027-03-30 -> 2027-08-30 2026-05-06
minor Completion pushed: 2027-04-30 -> 2027-09-30 2026-05-06
Trial Details
NCT Number NCT07536867
Lead Sponsor Antalya City Hospital
Conditions Breast Cancer, Lymph Node Dissection, Postoperative Pain, Mastectomy
Enrollment 60 participants
Start Date 2026-08-30
Primary Completion 2027-08-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-11